Merck & Co., Inc. - Company & Market Research Reports

Home /
Companies /
Merck & Co., Inc.

Merck & Co., Inc. is a global healthcare company with operations in more than 140 countries. It offers therapeutic and preventive agents to treat cardiovascular, type 2 diabetes, asthma, nasal allergy symptoms, allergic rhinitis, chronic hepatitis C virus and other diseases. The company has collaboration agreements with Adaptimmune Therapeutics plc and Agenus; and a research agreement with Proteros Biostructures. Founded in 1891, it is headquartered in Kenilworth, New Jersey.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 334
Infectious Diseases Drugs 245
Vaccines 240
Animal Healthcare/Veterinary 191
Endocrine and Metabolic Disorders Drugs 175
Immune Disorders Drugs 154
Animal Pharmaceuticals 135
Central Nervous System Drugs 133
Women's Health 132
Cardiovascular Drugs 126
Pharmaceuticals 112
Musculoskeletal Disorders Drugs 103
Drug Discovery 98
Biopharmaceuticals 95
Respiratory Drugs 81
Oncology 74
Clinical Trials 72
Allergy and Immunology 71
Sexual and Reproductive Health Drugs 71
Liver and Kidney Disorders Drugs 69
Diabetes Drugs 67
Antibiotics 62
Gastrointestinal Drugs 61
Biotechnology 60
Drug Delivery 59
Enzymes 57
Genomics 48
Analgesics 43
Optical Disorders Drugs 42
Dermatological Drugs 42
Brain Cancer Drugs 41
Skin Cancer Drugs 39
Infusions and Injectables 36
Diagnostics 36
Lymphoma Drugs 35
Pulmonary Medicine 34
Cancer Vaccines 33
Pharmaceutical Intermediates 32
Hematological Drugs 32
Biosimilars and Biosuperiors 32
Lung Cancer Drugs 30
Urological Disorders Drugs 29
Optical 28
HIV/AIDS Drugs 28
Pharmaceutical Manufacturing 28
Liver Cancer Drugs 26
Healthcare Services 25
Over the Counter (OTC) Drugs 25
Immunosuppressive Drugs 24
Neurology 23
Prostate Cancer Drugs 23
Infectious Disease Testing 23
Cervical Cancer Drugs 22
Allergy Drugs 22
Breast Cancer Drugs 21
Leukemia Drugs 21
Cardiology 21
Mental Disorders Drugs 19
Psoriasis Drugs 19
Asthma Drugs 18
Colon Cancer Drugs 17
Vitamins and Dietary Supplements 17
Drugs by Therapeutic Area 16
Inhalers and Nebulisers 16
Dermatology 16
E-Healthcare 15
Bladder Cancer Drugs 15
Medical Devices 15
Biomarkers 15
Gastroenterology 14
Fertility Services 13
Ovarian Cancer Drugs 13
Hematology 13
Pancreatic Cancer Drugs 13
Pediatrics 13
Alzheimer's Disease Drugs 13
Urology and Nephrology 12
Nanomedicine 12
Therapeutic Area 11
Generic Drugs 11
Transdermal and Transmucosal Drug Delivery 11
Kidney Cancer Drugs 11
Anti-Obesity Drugs 11
Respiratory Devices 10
Thyroid Cancer Drugs 10
In Vitro Diagnostics 9
Anesthetic Drugs 8
Mental Health 8
Uterine Cancer Drugs 7
Bronchitis Drugs 7
Proteomics 6
Healthcare 6
Other Healthcare Facilities 6
Laboratory Equipment 6
Endocrinology 6
Company Reports 5
Hepatology 5
Needles and Syringes 5
Cough and Cold Drugs 4
Surgical Procedures 4
Cardiovascular Devices 3
Diabetes Devices 3
Hospital Management 3
Molecular Diagnostics 3
Palliative Care 3
Acne Drugs 3
Anxiety Drugs 3
Schizophrenia Drugs 3
Addiction Disorders Drugs 2
Patient Monitoring Equipment 2
Pharmacoeconomics 2
Laboratory Testing 2
Dental 2
Mammography 2
Stem Cells 2
Blood Banking 2
Biomaterials 2
ENT Devices 2
Nursing 2
Surgical Devices 2
Endoscopy 2
Clinical Skills 2
Maternal and Neonatal Care 2
Orthopedic Devices 1
Dialysis 1
Cholesterol Testing 1
Managed Care 1
Neurology Devices 1
Contrast Media 1
Nuclear Medicine and Radiopharmacology 1
Anatomy 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



284 reviews

3,382 Results (Page 43 of 170)
- Relevance
  Sort by

Oral Antivirals Market - Global Strategic Business Report

 Report
August 2026
380 Pages
Global

From

€5234EUR$5,850USD£4,476GBP

Candidiasis Therapeutics Market - Global Strategic Business Report

 Report
August 2026
474 Pages
Global

From

€5234EUR$5,850USD£4,476GBP

Typhoid Treatment Market - Global Strategic Business Report

 Report
August 2026
366 Pages
Global

From

€5234EUR$5,850USD£4,476GBP

Cytomegalovirus (CMV) Treatment - Global Strategic Business Report

 Report
August 2026
384 Pages
Global

From

€5234EUR$5,850USD£4,476GBP

Aspergillosis Drugs - Global Strategic Business Report

 Report
August 2026
373 Pages
Global

From

€5234EUR$5,850USD£4,476GBP

NEED HELP FINDING THE RIGHT PRODUCT? Brian will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Pseudomonas Aeruginosa Infection Treatment Market - Global Strategic Business Report

 Report
August 2026
273 Pages
Global

From

€5234EUR$5,850USD£4,476GBP

Encephalitis Treatment - Global Strategic Business Report

 Report
August 2026
478 Pages
Global

From

€5234EUR$5,850USD£4,476GBP

Neglected Tropical Disease Treatment - Global Strategic Business Report

 Report
August 2026
294 Pages
Global

From

€5234EUR$5,850USD£4,476GBP

Caspofungin - Global Strategic Business Report

 Report
August 2026
279 Pages
Global

From

€5234EUR$5,850USD£4,476GBP

Cryptococcosis Therapeutics - Global Strategic Business Report

 Report
August 2026
473 Pages
Global

From

€5234EUR$5,850USD£4,476GBP

Infectious Disease Therapeutics - Global Strategic Business Report

 Report
August 2026
385 Pages
Global

From

€5234EUR$5,850USD£4,476GBP

Bird Flu Treatment Market - Global Strategic Business Report

 Report
August 2026
285 Pages
Global

From

€5234EUR$5,850USD£4,476GBP

Seasonal Allergic Rhinitis - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1118EUR$1,250USD£956GBP

Veterinary Vaccine Market - A Global and Regional Analysis: Focus on Type, Disease, Technology, Route of Administration, Distribution Channel, and Region - Analysis and Forecast, 2023-2033

 Report
January 2024
165 Pages
Global

From

€4429EUR$4,950USD£3,788GBP

Prescription Drugs - Global Strategic Business Report

 Report
August 2026
362 Pages
Global

From

€5234EUR$5,850USD£4,476GBP

Alopecia Drugs - Global Strategic Business Report

 Report
August 2026
187 Pages
Global

From

€5234EUR$5,850USD£4,476GBP

Open-Angle Glaucoma Therapeutics Market 2026-2030

 Report
January 2026
277 Pages
Global

From

€2237EUR$2,500USD£1,913GBP

Neurology Clinical Trials - Global Strategic Business Report

 Report
August 2026
385 Pages
Global

From

€5234EUR$5,850USD£4,476GBP

Hepatitis Vaccine Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

 Report
February 2024
78 Pages
Global

From

€3500EUR$4,190USD£3,098GBP

Pegfilgrastim- Biosimilar Insight, 2022

 Report
January 2022
60 Pages
Global

From

€1790EUR$2,000USD£1,530GBP

3,382 Results (Page 43 of 170)
- 1
- 41
- 42
- 43
- 44
- 45

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.